Finance

Lists
Outlook: 35.5% bullish·3.2% bearish
Go to analysis
JNJB34:BVMF
Johnson & Johnson BDR
R$85.25
-1.43%
(-1.24) 1D
Oct 19, 5:05:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for JNJB34...
Open
R$85.70
High
R$85.80
Low
R$84.81
Mkt. cap
611.61B
Avg. vol.
8.34K
Volume
2.92K
52-wk high
R$96.19
52-wk low
R$64.68
Shares outstanding
2.41B
No. of employees
138K
Open
R$85.70
High
R$85.80
Low
R$84.81
Mkt. cap
611.61B
Avg. vol.
8.34K
Volume
2.92K
52-wk high
R$96.19
52-wk low
R$64.68
Shares outstanding
2.41B
No. of employees
138K
News stories
From web sources and news partners
About Johnson & Johnson BDR
CEOJoaquin Duato
Employees138K
FoundedJan 1886
HeadquartersNew Brunswick, New Jersey, United States
SectorPharmaceutical industry
Websitejnj.com
Last report
Oct 13, 2026
Fiscal period
Q3 2026
$2.59 / $2.52
+2.69%beat
Revenue / Est. (USD)
25.40B / 25.38B
+0.07%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
24.56B
24.06B
25.31B
25.40B
Cost of goods sold
7.81B
8.09B
8.02B
8.10B
Cost of revenue
7.81B
8.09B
8.02B
8.10B
Research and development expenses
4.25B
3.53B
3.65B
4.65B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.61B
5.85B
6.25B
6.28B
Operating expense
10.86B
9.38B
9.91B
10.94B
Total operating expenses
18.68B
17.47B
17.92B
19.03B
Operating income
5.89B
6.60B
7.39B
6.36B
Other non operating income
396.00M
-211.00M
110.00M
-5.78B
EBT including unusual items
4.97B
5.99B
6.75B
34.00M
EBT excluding unusual items
6.03B
6.41B
7.42B
554.00M
Income tax expense
-150.00M
755.00M
1.21B
-176.00M
Effective tax rate
-3.02%
12.60%
17.98%
-517.65%
Other operating expenses
-
-
-
-
Net income
5.12B
5.24B
5.53B
210.00M
Net profit margin
20.83%
21.76%
21.86%
0.83%
Earnings per share
2.46
2.70
2.90
2.59
Interest and investment income
237.00M
229.00M
219.00M
-
Interest expense
-214.00M
-272.00M
-281.00M
-31.00M
Net interest expenses
23.00M
-43.00M
-62.00M
-31.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.90B
8.60B
9.35B
8.32B
Gain or loss from assets sale
-132.00M
12.00M
-55.00M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps